Prasco Laboratories began producing a generic medroxyprogesterone acetate injection in 2002. This injectable contraceptive is administered once every three months.
A study published in 2024 in the British Medical Journal found that medroxyprogesterone acetate injections raise the risk of meningioma to 5.6 times higher than in non-users. The product labeling mentions side effects like irregular bleeding and weight changes, but, it does not warn about the risk of the development of meningioma that might require surgery.
The medroxyprogesterone acetate in this contraceptive has been linked to several severe conditions:
The aforementioned study provides clear evidence for this and it links these injections to brain tumors that often need minvasive treatment.
If you received Prasco's shots and were diagnosed with meningioma, you might receive compensation that should cover medical expenses, lost wages, and pain and suffering. We know that a brain tumor diagnosis is very stressful. We will handle your case with care and expertise. We will provide a quick evaluation and if you qualify, we will connect you with a specialized attorney. If Prasco's injectable contraceptive has affected you, please seek legal help. It is your right to seek compensation for the harm you have suffered.